Crossmark

Exploration of the benefits and resistance mechanisms of immunotherapy based on PD-L1 expression, circulating tumor DNA and T-cell receptor profiles in advanced gastric cancer

Crossref DOI link: https://doi.org/10.1007/s00262-025-04248-0

Published Online: 2025-12-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gou, Miaomiao

Qian, Niansong

Zhang, Yong

Yan, Bingfa

Wang, Zhikuan

Dai, Guanghai
License Information

Text and Data Mining valid from 2025-12-19

Version of Record valid from 2025-12-19
More Information

Article History

Received: 9 June 2025

Accepted: 17 November 2025

First Online: 19 December 2025

Declarations

:

: The authors declare no conflict of interest.

: This retrospective study was approved by the independent ethics committee of the Chinese PLA General Hospital, and all the authors consented to participate in the study.

: All the authors had consent for publication.

Document is current

Any future updates will be listed below